CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives
Data(s) |
01/05/2014
|
---|---|
Formato |
application/pdf |
Identificador |
http://boris.unibe.ch/66977/1/CD62L%20%28L-Selectin%29%20Shedding.pdf Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (May 2014). CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives. Gastroenterology, 146(5), p. 239. Elsevier doi:10.7892/boris.66977 urn:issn:0016-5085 |
Idioma(s) |
eng |
Publicador |
Elsevier |
Relação |
http://boris.unibe.ch/66977/ |
Direitos |
info:eu-repo/semantics/restrictedAccess |
Fonte |
Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (May 2014). CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives. Gastroenterology, 146(5), p. 239. Elsevier |
Palavras-Chave | #610 Medicine & health |
Tipo |
info:eu-repo/semantics/conferenceObject info:eu-repo/semantics/publishedVersion PeerReviewed |